Download PDF
Semin Thromb Hemost 2011; 37(4): 349-354
DOI: 10.1055/s-0031-1276583
© Thieme Medical Publishers

Protein C Inhibitor

Joost C.M. Meijers1 , Heiko Herwald2
  • 1Departments of Vascular Medicine and Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • 2Department of Clinical Sciences, Section for Clinical and Experimental Infection Medicine, Lund University, Lund, Sweden
Further Information

Publication History

Publication Date:
30 July 2011 (online)

    Permissions and Reprints

ABSTRACT

Protein C inhibitor (PCI) is a serine protease inhibitor and was originally identified as an inhibitor of activated protein C (APC). However, PCI is not specific for APC and also inhibits several proteases involved in coagulation, fibrinolysis, cancer, wound healing, and fertility. The biological function of PCI is unknown due to broad enzyme specificity, its wide tissue distribution, and the lack of a suitable animal model. This review highlights the specific roles of PCI in the areas of hemostasis and thrombosis and fertilization, and it also describes the latest information on the fascinating participation of the protein in intracellular processes, phospholipid binding, and killing of bacteria.

KEYWORDS

Protein C inhibitor - SERPIN - inhibition

REFERENCES

  • 1 Suzuki K, Deyashiki J, Nishioka K et al.. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily.  J Biol Chem. 1987;  262 (2) 611-616
    PubMedGoogle Scholar
  • 2 Meijers J CM, Chung D W. Organization of the gene coding for human protein C inhibitor (plasminogen activator inhibitor-3). Assignment of the gene to chromosome 14.  J Biol Chem. 1991;  266 (23) 15028-15034
    PubMedGoogle Scholar
  • 3 Marlar R A, Griffin J H. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.  J Clin Invest. 1980;  66 (5) 1186-1189
    CrossrefPubMedGoogle Scholar
  • 4 Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization.  J Biol Chem. 1983;  258 (1) 163-168
    PubMedGoogle Scholar
  • 5 Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor.  J Biochem. 1984;  95 (1) 187-195
    PubMedGoogle Scholar
  • 6 Meijers J CM, Kanters DHAJ, Vlooswijk R AA, van Erp H E, Hessing M, Bouma B N. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.  Biochemistry. 1988;  27 (12) 4231-4237
    CrossrefPubMedGoogle Scholar
  • 7 Rezaie A R, Cooper S T, Church F C, Esmon C T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.  J Biol Chem. 1995;  270 (43) 25336-25339
    CrossrefPubMedGoogle Scholar
  • 8 Elisen MGML, von dem Borne P AK, Bouma B N, Meijers J CM. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.  Blood. 1998;  91 (5) 1542-1547
    PubMedGoogle Scholar
  • 9 Stump D C, Thienpont M, Collen D. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.  J Biol Chem. 1986;  261 (27) 12759-12766
    PubMedGoogle Scholar
  • 10 Heeb M J, España F, Geiger M, Collen D, Stump D C, Griffin J H. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.  J Biol Chem. 1987;  262 (33) 15813-15816
    PubMedGoogle Scholar
  • 11 Stief T W, Radtke K P, Heimburger N. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.  Biol Chem Hoppe Seyler. 1987;  368 (10) 1427-1433
    CrossrefPubMedGoogle Scholar
  • 12 Mosnier L O, Elisen MGLM, Bouma B N, Meijers J CM. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.  Thromb Haemost. 2001;  86 (4) 1057-1064
    PubMedGoogle Scholar
  • 13 Hermans J M, Jones R, Stone S R. Rapid inhibition of the sperm protease acrosin by protein C inhibitor.  Biochemistry. 1994;  33 (18) 5440-5444
    CrossrefPubMedGoogle Scholar
  • 14 Elisen MGLM, van Kooij R J, Nolte M A et al.. Protein C inhibitor may modulate human sperm-oocyte interactions.  Biol Reprod. 1998;  58 (3) 670-677
    CrossrefPubMedGoogle Scholar
  • 15 Ecke S, Geiger M, Resch I et al.. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.  J Biol Chem. 1992;  267 (10) 7048-7052
    PubMedGoogle Scholar
  • 16 Luo L Y, Jiang W. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.  Biol Chem. 2006;  387 (6) 813-816
    CrossrefPubMedGoogle Scholar
  • 17 Hobson J P, Netzel-Arnett S, Szabo R et al.. Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes.  J Biol Chem. 2004;  279 (45) 46981-46994
    CrossrefPubMedGoogle Scholar
  • 18 Szabo R, Netzel-Arnett S, Hobson J P, Antalis T M, Bugge T H. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.  Biochem J. 2005;  390 (Pt 1) 231-242
    CrossrefPubMedGoogle Scholar
  • 19 Cardin A D, Weintraub H JR. Molecular modeling of protein-glycosaminoglycan interactions.  Arteriosclerosis. 1989;  9 (1) 21-32
    CrossrefPubMedGoogle Scholar
  • 20 Kuhn L A, Griffin J H, Fisher C L et al.. Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.  Proc Natl Acad Sci U S A. 1990;  87 (21) 8506-8510
    CrossrefPubMedGoogle Scholar
  • 21 Pratt C W, Church F C. Heparin binding to protein C inhibitor.  J Biol Chem. 1992;  267 (13) 8789-8794
    PubMedGoogle Scholar
  • 22 Shirk R A, Elisen MGLM, Meijers J CM, Church F C. Role of the H helix in heparin binding to protein C inhibitor.  J Biol Chem. 1994;  269 (46) 28690-28695
    PubMedGoogle Scholar
  • 23 Elisen MGLM, Maseland M HH, Church F C, Bouma B N, Meijers J CM. Role of the A + helix in heparin binding to protein C inhibitor.  Thromb Haemost. 1996;  75 (5) 760-766
    PubMedGoogle Scholar
  • 24 Huntington J A, Kjellberg M, Stenflo J. Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation.  Structure. 2003;  11 (2) 205-215
    CrossrefPubMedGoogle Scholar
  • 25 Li W, Adams T E, Kjellberg M, Stenflo J, Huntington J A. Structure of native protein C inhibitor provides insight into its multiple functions.  J Biol Chem. 2007;  282 (18) 13759-13768
    CrossrefPubMedGoogle Scholar
  • 26 Li W, Adams T E, Nangalia J, Esmon C T, Huntington J A. Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex.  Proc Natl Acad Sci U S A. 2008;  105 (12) 4661-4666
    CrossrefPubMedGoogle Scholar
  • 27 Huntington J A, Li W. Structural insights into the multiple functions of protein C inhibitor.  Cell Mol Life Sci. 2009;  66 (1) 113-121
    CrossrefPubMedGoogle Scholar
  • 28 Jerabek I, Zechmeister-Machhart M, Binder B R, Geiger M. Binding of retinoic acid by the inhibitory serpin protein C inhibitor.  Eur J Biochem. 2001;  268 (22) 5989-5996
    CrossrefPubMedGoogle Scholar
  • 29 Geiger M. Protein C inhibitor, a serpin with functions in- and outside vascular biology.  Thromb Haemost. 2007;  97 (3) 343-347
    PubMedGoogle Scholar
  • 30 Wakita T, Hayashi T, Yuasa H, Nishioka J, Kawamura J, Suzuki K. Molecular cloning, tissue distribution and androgen regulation of rat protein C inhibitor.  FEBS Lett. 1998;  429 (3) 263-268
    CrossrefPubMedGoogle Scholar
  • 31 Wagenaar G TM, van Vuuren A JH, Girma M et al.. Characterization of transgenic mice that secrete functional human protein C inhibitor into the circulation.  Thromb Haemost. 2000;  83 (1) 93-101
    PubMedGoogle Scholar
  • 32 Uhrin P, Dewerchin M, Hilpert M et al.. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility.  J Clin Invest. 2000;  106 (12) 1531-1539
    CrossrefPubMedGoogle Scholar
  • 33 Wagenaar G TM, Uhrin P, Weipoltshammer K et al.. Expression patterns of protein C inhibitor in mouse development.  J Mol Histol. 2010;  41 (1) 27-37
    CrossrefPubMedGoogle Scholar
  • 34 Hayashi T, Nishioka J, Nakagawa N et al.. Protein C inhibitor directly and potently inhibits activated hepatocyte growth factor activator.  J Thromb Haemost. 2007;  5 (7) 1477-1485
    CrossrefPubMedGoogle Scholar
  • 35 España F, Vicente V, Tabernero D, Scharrer I, Griffin J H. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.  Thromb Res. 1990;  59 (3) 593-608
    CrossrefPubMedGoogle Scholar
  • 36 Tabernero D, España F, Vicente V, Estellés A, Gilabert J, Aznar J. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.  Thromb Haemost. 1990;  63 (3) 380-382
    PubMedGoogle Scholar
  • 37 Minamikawa K, Wada H, Wakita Y et al.. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.  Thromb Haemost. 1994;  71 (2) 192-194
    PubMedGoogle Scholar
  • 38 Carroll V A, Griffiths M R, Geiger M et al.. Plasma protein C inhibitor is elevated in survivors of myocardial infarction.  Arterioscler Thromb Vasc Biol. 1997;  17 (1) 114-118
    CrossrefPubMedGoogle Scholar
  • 39 Meijers J CM, Marquart J A, Bertina R M, Bouma B N, Rosendaal F R. Protein C inhibitor (plasminogen activator inhibitor-3) and the risk of venous thrombosis.  Br J Haematol. 2002;  118 (2) 604-609
    CrossrefPubMedGoogle Scholar
  • 40 Strandberg K, Stenflo J, Nilsson C, Svensson P J. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with factor V Leiden.  J Thromb Haemost. 2005;  3 (11) 2578-2580
    CrossrefPubMedGoogle Scholar
  • 41 Strandberg K, Svensson P J, Ohlin A K. Venous thromboembolism in carriers of the factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.  Thromb Res. 2007;  121 (2) 145-151
    CrossrefPubMedGoogle Scholar
  • 42 Kölbel T, Goncalves I, Dias N, Strandberg K, Acosta S, Gottsäter A. Coagulation activation and ultrasound characteristics in patients with carotid artery disease.  Thromb Res. 2010;  125 (2) 171-177
    CrossrefPubMedGoogle Scholar
  • 43 Undén J, Strandberg K, Malm J et al.. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.  J Neurol. 2009;  256 (1) 72-77
    CrossrefPubMedGoogle Scholar
  • 44 Nilsson G, Strandberg K, Astermark J, Vernersson E, Stenflo J, Berntorp E. The APC-PCI complex concentration predicts outcome of aortic surgery.  Thromb Res. 2007;  120 (2) 237-244
    CrossrefPubMedGoogle Scholar
  • 45 Bakoush O, Ohlin A K, Strandberg K, Kurkus J. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.  Nephron Clin Pract. 2008;  110 (3) c151-c157
    CrossrefPubMedGoogle Scholar
  • 46 Matsumoto K, Yano Y, Gabazza E C et al.. Inverse correlation between activated protein C generation and carotid atherosclerosis in type 2 diabetic patients.  Diabet Med. 2007;  24 (12) 1322-1328
    CrossrefPubMedGoogle Scholar
  • 47 Blomstrand D, Kölbel T, Lindblad B, Gottsäter A. Activated protein C-protein C inhibitor complex in peripheral arterial disease.  Ann Vasc Surg. 2010;  24 (5) 588-595
    CrossrefPubMedGoogle Scholar
  • 48 Schulman S, Eelde A, Blombäck M, Stenflo J. The plasma concentration of activated protein C appears normal in patients with haemophilia.  Haemophilia. 2009;  15 (2) 566-570
    CrossrefPubMedGoogle Scholar
  • 49 Kölbel T, Strandberg K, Mattiasson I, Stenflo J, Lindblad B. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms.  J Vasc Surg. 2006;  43 (5) 935-939
    CrossrefPubMedGoogle Scholar
  • 50 Kölbel T, Donath T, Strandberg K et al.. Is increased thrombin activation in patients with abdominal aortic aneurysms dependent on area or volume of aneurysm thrombus mass?.  Angiology. 2010;  61 (1) 113-118
    CrossrefPubMedGoogle Scholar
  • 51 Elf J L, Strandberg K, Svensson P J. The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis.  J Thromb Thrombolysis. 2010;  29 (4) 465-470
    CrossrefPubMedGoogle Scholar
  • 52 Uhrin P, Schöfer C, Zaujec J et al.. Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): localization of PCI in mouse testis and failure of single plasminogen activator knockout to restore spermatogenesis in PCI-deficient mice.  Fertil Steril. 2007;  88 (4, Suppl) 1049-1057
    CrossrefPubMedGoogle Scholar
  • 53 España F, Navarro S, Medina P, Zorio E, Estellés A. The role of protein C inhibitor in human reproduction.  Semin Thromb Hemost. 2007;  33 (1) 41-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 54 Suzuki K, Kise H, Nishioka J, Hayashi T. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system.  Semin Thromb Hemost. 2007;  33 (1) 46-52
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 España F, Sánchez-Cuenca J, Fernández P J et al.. Inhibition of human sperm-zona-free hamster oocyte binding and penetration by protein C inhibitor.  Andrologia. 1999;  31 (4) 217-223
    CrossrefPubMedGoogle Scholar
  • 56 Gianotten J, Schimmel A W, van der Veen F, Lombardi M P, Meijers J CM. Absence of mutations in the PCI gene in subfertile men.  Mol Hum Reprod. 2004;  10 (11) 807-813
    CrossrefPubMedGoogle Scholar
  • 57 Bungum M, Giwercman A, Bungum L, Humaidan P, Rastkhani H, Giwercman Y L. Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure.  Fertil Steril. 2010;  93 (1) 277-279
    CrossrefPubMedGoogle Scholar
  • 58 Fujimoto H, Gabazza E C, Hataji O et al.. Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease.  Am J Respir Crit Care Med. 2003;  167 (12) 1687-1694
    CrossrefPubMedGoogle Scholar
  • 59 Nishii Y, Gabazza E C, Fujimoto H et al.. Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension.  J Thromb Haemost. 2006;  4 (11) 2331-2339
    CrossrefPubMedGoogle Scholar
  • 60 Kan M, Zhang G H, Zarnegar R et al.. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE.  Biochem Biophys Res Commun. 1991;  174 (1) 331-337
    CrossrefPubMedGoogle Scholar
  • 61 Hamada T, Kamada H, Hayashi T et al.. Protein C inhibitor regulates hepatocyte growth factor activator-mediated liver regeneration in mice.  Gut. 2008;  57 (3) 365-373
    CrossrefPubMedGoogle Scholar
  • 62 Han M H, Hwang S I, Roy D B et al.. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.  Nature. 2008;  451 (7182) 1076-1081
    CrossrefPubMedGoogle Scholar
  • 63 Rosenzweig C N, Zhang Z, Sun X et al.. Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers.  J Urol. 2009;  181 (3) 1407-1414
    CrossrefPubMedGoogle Scholar
  • 64 Suzuki K, Hayashi T. Protein C and its inhibitor in malignancy.  Semin Thromb Hemost. 2007;  33 (7) 667-672
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Nishioka J, Ning M, Hayashi T, Suzuki K. Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles.  J Biol Chem. 1998;  273 (18) 11281-11287
    CrossrefPubMedGoogle Scholar
  • 66 Malleier J M, Oskolkova O, Bochkov V et al.. Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids.  Blood. 2007;  109 (11) 4769-4776
    CrossrefPubMedGoogle Scholar
  • 67 Baumgärtner P, Geiger M, Zieseniss S et al.. Phosphatidylethanolamine critically supports internalization of cell-penetrating protein C inhibitor.  J Cell Biol. 2007;  179 (4) 793-804
    CrossrefPubMedGoogle Scholar
  • 68 Andersson E, Rydengård V, Sonesson A, Mörgelin M, Björck L, Schmidtchen A. Antimicrobial activities of heparin-binding peptides.  Eur J Biochem. 2004;  271 (6) 1219-1226
    CrossrefPubMedGoogle Scholar
  • 69 Malmström E, Mörgelin M, Malmsten M et al.. Protein C inhibitor—a novel antimicrobial agent.  PLoS Pathog. 2009;  5 (12) e1000698
    CrossrefPubMedGoogle Scholar

Joost C.M. MeijersPh.D. 

Experimental Vascular Medicine, G1-143, Academic Medical Center

Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

Email: j.c.meijers@amc.uva.nl